Two-dose, inactivated vaccine

Development status

  1. Emergency use/conditional marketing authorizations granted in multiple countries
  2. Phase 3 clinical trials underway in multiple countries
countries with procurement contracts

Emergency use
authorizations granted in:

Drugs to Watch - CoronaVac Placeholder
Drugs to Watch - CoronaVac


The vaccine is easily distributed and stored.

The efficacy remains to be determined, with rates as low as 50% reported by Brazil, but the vaccine can reportedly reduce the need for hospitalization and the most severe forms of COVID-19 by 100%.

Drugs to Watch 2021

Drugs to Watch
Drugs to Watch
Drugs to Watch
Drugs to Watch

From innovation to bottom line

Access our global intelligence, advanced analytics and global team of experts.

Contact our team